Clinical Trial Update: Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System

View source ↗

Summary

This document provides an update on a retrospective long-term safety and efficacy study of the Beta-Cath 3.5F System. It pertains to coronary in-stent restenosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary In-stent Restenosis

Drugs mentioned

• Beta-Cath 3.5F System

Snippet

Sponsor: Best Vascular, Inc. | Conditions: Coronary In-stent Restenosis | Status: UNKNOWN